The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 19 February 2002. doi:10.1084/jem.20011658
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zippelius, A.
Right arrow Articles by Romero, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zippelius, A.
Right arrow Articles by Romero, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2002/2/485/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 4, February 18, 2002 485-494


Original Article

Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans

Alfred Zippelius1, Mikaël J. Pittet1, Pascal Batard1, Nathalie Rufer4, Magda de Smedt5, Philippe Guillaume6, Kim Ellefsen2, Danila Valmori1, Danielle Liénard1,3, Jean Plum5, H. Robson MacDonald6, Daniel E. Speiser1, Jean-Charles Cerottini6 and Pedro Romero1

1 Division of Clinical Onco-Immunology, University Hospital (CHUV), 1011 Lausanne, Switzerland
2 Division of Immunology and Allergy, University Hospital (CHUV), 1011 Lausanne, Switzerland
3 Multidisciplinary Oncology Center, University Hospital (CHUV), 1011 Lausanne, Switzerland
4 NCCR Molecular Oncology, Swiss Institute for Experimental Cancer Research, 1066 Epalinges, Switzerland
5 Department of Clinical Chemistry, Microbiology and Immunology, University Hospital, 9000 Ghent, Belgium
6 Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, 1066 Epalinges, Switzerland

Address correspondence to Pedro Romero, Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Hôpital Orthopédique, Niveau 5, Aile Est, Avenue Pierre Decker 4, 1005 Lausanne, Switzerland. Phone: 41-21-3140-176; Fax: 41-21-3147-477; E-mail: pedro.romero{at}isrec.unil.ch

The low frequency of self-peptide–specific T cells in the human preimmune repertoire has so far precluded their direct evaluation. Here, we report an unexpected high frequency of T cells specific for the self-antigen Melan-A/MART-1 in CD8 single–positive thymocytes from human histocompatibility leukocyte antigen-A2 healthy individuals, which is maintained in the peripheral blood of newborns and adults. Postthymic replicative history of Melan-A/MART-1–specific CD8 T cells was independently assessed by quantifying T cell receptor excision circles and telomere length ex vivo. We provide direct evidence that the large T cell pool specific for the self-antigen Melan-A/MART-1 is mostly generated by thymic output of a high number of precursors. This represents the only known naive self-peptide–specific T cell repertoire directly accessible in humans.

Key Words: TREC • Telomere • Melan-A/MART-1 • naive • CD8


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS